Navigation Links
Drops of Fatty Acid Curb Symptoms of Dry Eye Syndrome
Date:2/13/2008

Mouse study suggests new treatment options without unwanted side effects

WEDNESDAY, Feb. 13 (HealthDay News) -- Eye drops containing alpha-linolenic acid (ALA) significantly reduced symptoms of dry eye syndrome in mice, a new study says.

ALA is an omega-3 fatty acid that's not made by the body and has to be obtained through diet. Dry eye, which affects about 10 million people in the United States, causes symptoms such as stinging, burning, irritation or a feeling of scratchiness. It can lead to problems with day-to-day activities such as driving and reading.

Currently, treatment options are limited in terms of effectiveness and undesirable side effects, according to background information in the study, published in the February issue of the journal Archives of Ophthalmology.

Dr. Reza Dana, a Harvard Medical School professor and Cornea Service Director at the Massachusetts Eye and Ear Infirmary, and colleagues at the Schepens Eye Research Institute tested three formulations of fatty acids: 0.2 percent ALA; 0.2 percent linoleic acid (an omega-6 fatty acid); and 0.01 percent ALA combined with 0.1 percent linoleic acid.

Some mice received once-a-day treatment with these eye drops, while other mice did not receive any eye drops. The eyes of mice treated with ALA showed a significant reversal in epithelial damage to the cornea, which is the transparent dome that covers the pupil.

"The current study for the first time demonstrates the benefit of topical application of a particular fatty acid in treating the signs of dry eye syndrome at both the molecular and cellular levels," Dana noted.

"Using topical formulations of fatty acids to treat dry eye would allow for more flexibility for treatment, including lessening side effects that patients can experience from oral intake of fatty acids. Clinical studies with topical fatty acids are being planned, which, if successful, could alter the m
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New buffer resists pH change, even as temperature drops
2. Over-the-counter eardrops may cause hearing loss or damage
3. Over-the-counter eardrops may cause hearing loss or damage
4. Diet Change Can Curb Fatty Liver Disease
5. Attenuation of NASH by stimulation of free fatty acid metabolism
6. New treatment effective in counteracting cocaine-induced symptoms
7. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
8. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
9. New study: Pine bark reduces perimenopausal symptoms
10. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
11. Clean to Ease Allergy and Asthma Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drops of Fatty Acid Curb Symptoms of Dry Eye Syndrome
Drops of Fatty Acid Curb Symptoms of Dry Eye Syndrome
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...significant prognosis and extension of lifetime of... based on dendritic cells, which help the immune s...rue, this represents the first proof of principle ...history of a solid tumor”, says Philip Kantoff, Ch...
...has ruled that HIV-positive people don't have to d...f condoms are used. Justin Dalley was charged wit... female partner his HIV positive status before the... unprotected oral sex. However, Judge Susan Thomas...
... to children to combat minor infections has always...nity. But among the antibiotics that are generally...y safest one. Not any longer, if researchers from ... These researchers found that using amoxicillin t...
...y of rural health care is ensuring availability of...unity health centres (CHCs) due to recruitment del...basic amenities and incentives. An important reaso...lack of accountability in our public health servic...
Other Medicine News:Health News:Problems in rural health delivery and remedies 2
(Date:10/6/2008)... children, parents discussing clinical ...6 /PRNewswire-USNewswire/ -- From asthma and cance...es lives and improves their,health and well-being....alth (NIH), "Children and Clinical Studies", (http... offers parents and health,care providers an insid...
(Date:10/6/2008)...- Genaera,Corporation (Nasd...ase 1,clinical trial of trodusquemine (MSI-1436), ... type 2 diabetes and obesity. MSI-1436 is a novel,...hat controls the function,of both the leptin and i...appetite. In the study, MSI-1436 was found to be w...
(Date:10/6/2008)...ate 6 Weeks of Radiation Therapy -, Event: Watch S...ednesday, October 22, 2008, 3 - 4 p.m. by visit...ON, Va., Oct. 6 / Questions raced thr...breast cancer in May. Would she have the,tumor rem...chemotherapy?, , To view the Multimedia News Rel...
(Date:10/3/2008)...s the newest study site, PHILADELPHIA, Oct. 3 /PR... Philadelphia today received a contract to manage ... Children,s Hospital will manage local,participati...County, New,Jersey. The study is funded by the Nat...pate approximately 1,000 families in Burlington,Co...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2MedQuist Announces Additions to Board of Directors 7496 1MedQuist Announces Additions to Board of Directors 7496 2MedQuist Announces Additions to Board of Directors 7496 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 1BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30 2008 7494 9Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 1Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 2Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4733 4Cyprus and Ireland Add Wyeths 7 Valent Pneumococcal Conjugate Vaccine 28PCV7 29 to Their National Immunisation Schedules 7491 1Cyprus and Ireland Add Wyeths 7 Valent Pneumococcal Conjugate Vaccine 28PCV7 29 to Their National Immunisation Schedules 7491 2Cyprus and Ireland Add Wyeths 7 Valent Pneumococcal Conjugate Vaccine 28PCV7 29 to Their National Immunisation Schedules 7491 3
...R, British Columbia--(BUSINESS WIRE)--May 23, 2007...d the results of,studies conducted by ITTEC Stem, ...ng results using AAGP(TM) in the cryopreservation,...tance of this,molecule in the rapidly expanding st...s using AAGP(TM) on human embryonic stem cells., U...
...-(BUSINESS WIRE)--May 22, 2007 - MIV Therapeutics,...t generation,biocompatible coatings and advanced d... other implantable medical devices, is,pleased to ...ng its,proprietary polymer free Hydroxyapatite-coa... Cypher Stent will be presented at,this weeks Euro...
Other Medicine Technology:ProtoKinetix's AAGP Dramatically Increases Recovery Rate of,Cryopreserved Stem Cells 2MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 2MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 3MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007 4
...tem will define the state of knee implants. Now, f... requirements and increasing surgical options, whi...ons. The GENESIS II femoral components meet these...tomeet todays surgical demands. Clinical issues su...
Cruciate retaining, posterior stabilized and constrained components.
...tmental total knee prosthesis stems from many year...he-art design and manufacturing technologies have ...l function as well as a favorable pressure distrib... keep wear to a minimum. The inherent design of th...
Offset Liners - Plus 5 mm Neutral
Medicine Products: